FRANKLIN RESOURCES INC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$6,759,026
-18.4%
189,594
+5.6%
0.00%
-25.0%
Q2 2023$8,285,779
+15.1%
179,618
+0.1%
0.00%0.0%
Q1 2023$7,197,629
-14.2%
179,492
-0.9%
0.00%0.0%
Q4 2022$8,389,992
+13.6%
181,092
+1.5%
0.00%0.0%
Q3 2022$7,386,000
-30.9%
178,363
-0.5%
0.00%
-20.0%
Q2 2022$10,691,000
-17.8%
179,1970.0%0.01%0.0%
Q1 2022$13,013,000
-13.6%
179,197
-0.0%
0.01%0.0%
Q4 2021$15,070,000
-17.5%
179,211
-11.5%
0.01%
-28.6%
Q3 2021$18,260,000
-5.4%
202,461
+0.0%
0.01%0.0%
Q2 2021$19,298,000
-16.3%
202,385
-0.0%
0.01%
-22.2%
Q1 2021$23,048,000
-34.5%
202,427
-20.3%
0.01%
-40.0%
Q4 2020$35,172,000
+11.8%
254,078
-33.6%
0.02%0.0%
Q3 2020$31,464,000
-0.8%
382,827
+0.1%
0.02%
-6.2%
Q2 2020$31,726,000
+86.7%
382,4730.0%0.02%
+45.5%
Q1 2020$16,993,000
+7.3%
382,473
+3.2%
0.01%
+37.5%
Q4 2019$15,830,000
+154.4%
370,650
+154.8%
0.01%
+166.7%
Q3 2019$6,222,000
-71.6%
145,450
-32.1%
0.00%
-70.0%
Q2 2015$21,942,000
+64.9%
214,3000.0%0.01%
+66.7%
Q1 2015$13,306,000
+41.5%
214,3000.0%0.01%
+50.0%
Q4 2014$9,403,000
-24.8%
214,300
-2.9%
0.00%
-33.3%
Q3 2014$12,497,000
+14.5%
220,800
-9.2%
0.01%
+20.0%
Q2 2014$10,913,000
-8.2%
243,1000.0%0.01%
-16.7%
Q1 2014$11,885,000243,1000.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2022
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders